Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pharmacol Ther. Aug 6, 2014; 5(3): 148-155
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.148
Figure 1
Figure 1 Gastric motor abnormalities reported during critical illness. CCK: Cholecystokinin; PYY: peptide YY.
Figure 2
Figure 2 Efficacy of metoclopramide (A), erythromycin (B) and combined erythromycin and metoclopramide (C) in the treatment of feed intolerance of critical illness over 7-d period.
Figure 3
Figure 3 Efficacy of rescue combined metoclopramide and erythromycin in critically ill patients who failed to response to either erythromycin or metoclopramide in the treatment of feed intolerance.